Holguín is the leading province in anti-D plasma donors, with 14 registered donors (10 currently eligible) who provide plasma twice a month and are monitored to ensure quality.

Two wards at the Lucía Íñiguez Landín Clinical-Surgical Hospital in Holguín will resume services after undergoing repairs aimed at improving comfort and facility conditions.

Cuban President Miguel Díaz-Canel praised the HEBERSaVax vaccine candidate, a unique therapeutic immunotherapy designed to treat various malignant tumors. Developed in Cuba, the product has shown promising results in Phase II clinical trials, offering hope for cancer patients with minimal side effects.

Mexican President Claudia Sheinbaum praised the bilateral agreement allowing Cuban doctors to provide services in Mexico, where they are, she emphasized, a great help.